Neisseria meningitidis is a major cause of bacterial meningitis and septicaemia worldwide
and is associated with high case fatality rates and serious life-long complications among …

Neisseria meningitidis is the main cause of meningitis and sepsis, potentially life-threatening
conditions. Thanks to advancements in vaccine development, vaccines are now available …

This report compiles and summarizes all recommendations from CDC's Advisory Committee
on Immunization Practices (ACIP) for use of meningococcal vaccines in the United States …

Background The meningococcal group B vaccine 4CMenB is a new, recombinant protein-
based vaccine that is licensed to protect against invasive group B meningococcal disease …

Glycoconjugate vaccines based on bacterial capsular polysaccharides (CPS) have been
extremely successful in preventing bacterial infections. The glycan antigens for the …

Background The epidemiology of acute bacterial meningitis has changed substantially since
the introduction of conjugate vaccines. Methods We analyzed nationwide surveillance data …

Invasive meningococcal disease (IMD) is a serious disease that is fatal in 5–15% and
disabling in 12–20% of cases. The dynamic and unpredictable epidemiology is a particular …

Meningococcal disease remains an important cause of morbidity and death worldwide
despite the development and increasing implementation of effective vaccines. Elimination of …

Infections with Neisseria meningitidis and Neisseria gonorrhoeae have different clinical
manifestations, but the bacteria share up to 80–90% genome sequence identity. The …

The control of meningitis, meningococcemia and other infections caused by Neisseria
meningitidis is a significant global health challenge. Substantial progress has occurred in …